Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target
Melanie Weingart(Sidney Kimmel Comprehensive Cancer Center), Eric H. Raabe(Johns Hopkins University), Anat Erdreich‐Epstein(University of Southern California), Jaclyn A. Biegel(Children's Hospital of Philadelphia), Xinggang Mao(Johns Hopkins University), Tracy Busse(Children's Hospital of Philadelphia), Brent A. Orr(St. Jude Children's Research Hospital), Antoinette Price(Johns Hopkins University), Jeffrey Rubens(Johns Hopkins University), Harpreet Kaur(Johns Hopkins University), Yasumichi Kuwahara(Kyoto Prefectural University of Medicine), Isabella Taylor(Johns Hopkins University), Marianne Hütt-Cabezas(NYU Langone Health), Sariah J. Allen(St. Jude Children's Research Hospital), Rachael Maynard(Johns Hopkins University), Jingying Xu(Tongji University), Bernard E. Weissman(University of North Carolina at Chapel Hill), Jacquelyn J. Roth(UPMC Hillman Cancer Center), Charles G. Eberhart(Johns Hopkins University)
Cited by 85
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711